Delivery Order SPE2DB22D2206-SPE2DB23FFQ50
- Not listed
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Norvasc 10 mg tablets, a cardiovascular medication, valued at $1,086.46. The order has an ultimate completion date of August 2, 2024 and is a Firm Fixed Price contract type. This Delivery Order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,895.14 firm-fixed-price delivery order is for the supply of 4,565,597,451 units of the prescription drug Norvasc (amlodipine besylate) 5 mg tablets. The contract has an ultimate completion date of August 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that...
- This federal contract award, with ID SPE2DB22D1041|SPE2DB24FTYR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,121.11 firm-fixed-price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NORVASC 2.5 mg tablets. The contract has a firm-fixed price of $1,792.72 and an ultimate completion date of August 28, 2024. It was awarded as a delivery order, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is likely part of a larger Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical firm Amerisourcebergen Corporation. The $119,298.45 order is for the supply of Norvasc 10mg tablets to support DLA Troop Support Medical programs and facilities. As a prime contractor, Amerisourcebergen Drug Corp has an extensive history of providing a range of pharmaceutical products and medical supplies to the Department of Defense....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,093.44 firm-fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is not set aside for any specific business type. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB20D3104|SPE2DB22FV6E8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,314.76 Firm Fixed Price contract is for the delivery of 4556882400 tablets of NORVASC 2.5 MG, a medication used to treat high blood pressure and chest pain. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,167.46 firm fixed price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a pharmaceutical product, in support of military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,405,076 Norvasc 5mg tablets. The award has a ceiling value of $13,425.43 and an ultimate completion date of August 12, 2024. The contract is a firm-fixed-price type with no set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, leverages its extensive supply chain capabilities to provide a wide range of medical commodities to support various...
- This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FFQ50Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $83,150.57, is for the delivery of 90-count bottles of Norvasc 10 mg tablets, a medication used to treat high blood pressure and chest pain. The contract has a completion date of February 10, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, worth up to $999,999,999 and $750,000, respectively, for the supply of a wide range of pharmaceutical products and medical supplies to support military, veteran, and federal law enforcement healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $83.2k | 2/9/23 |